Figure 3. Anti-HEV dynamics after Hecolin® vaccination. Participants who received Hecolin® according to the protocol and were tested for anti-HEV at month 0 and month 7 (immunogenicity analysis set) were included. Solid black line: HBsAg (+) participants; dashed gray lines: HBsAg (-) participants. GMC, geometric mean concentration. 95% CI is shown.